Whether you're tracking dilution filings, biotech catalysts, market signals, or land parcels — we're here to make sure every platform works as hard as you do.
Guerilla Finance operates a fleet of specialized financial and real estate intelligence platforms. Find the right contact for your platform below.
SEC filing alerts, dilution risk scores, stock tracking, institutional 13F analysis, and the Pulse dashboard.
LiveFDA catalyst tracking, PDUFA calendar, clinical trial monitoring, biotech screening, and pipeline intelligence.
LiveMarket convergence signals, multi-indicator technical analysis, and cross-platform fundamental data integration.
LiveReal estate intelligence, parcel scoring, zoning analysis, flood risk mapping, and property data aggregation.
LiveAccount issues, billing, API marketplace, partnership inquiries, and anything that doesn't fit a specific platform.
Our SEC EDGAR sentinel processes new filings continuously. From the moment a filing hits EDGAR to the moment your alert lands in your inbox — typically under 60 seconds. Basic and Premium subscribers receive real-time alerts. Free tier users receive a daily digest.
The Dilution Score is a proprietary 5-component model that evaluates: filing severity and type classification, float erosion risk based on outstanding shares analysis, warrant and convertible securities detection via XBRL parsing, institutional holdings movement from 13F data, and historical dilution patterns for the company. Each component is data-driven — no subjective ratings, no guesswork.
Free accounts monitor up to 3 tickers. Basic ($29/mo) supports 15 tickers with real-time alerts. Premium ($59/mo) supports 40 tickers with AI analysis, institutional tracking, and Excel export. All tiers include full Pulse dashboard access.
Pulse is our live market intelligence view — a real-time dilution risk radar across every public company in our system. It shows active dilution scores, recent filing activity, and risk trends at a glance. Think of it as your early warning system for the entire market.
We monitor all SEC filing types relevant to dilution: S-3 shelf registrations, S-1 registration statements, prospectus supplements (424B), 8-K current reports with dilution indicators, warrant exercises, convertible note conversions, and more. Our classifier categorizes each filing by dilution relevance and severity.
Yes. No contracts, no cancellation fees, no hidden terms. Cancel directly from your account settings and your access continues through the end of your billing period. We keep your business by earning it, not by trapping you.
All connections are encrypted via TLS. Authentication uses secure session tokens. API endpoints are rate-limited and access-controlled by subscription tier. Payment processing is handled by Stripe — we never see or store your card details. Our infrastructure runs in containerized isolation with authenticated email delivery (DKIM, SPF, DMARC verified).
Accuracy is everything to us. If you spot a discrepancy in a dilution score, filing classification, or any data point, reach out immediately via the contact form or email support@dilutionwatch.com. We investigate every report and we take them seriously.
The Catalyst Score is a composite metric that quantifies the significance and potential market impact of upcoming biotech events. It factors in trial phase, therapeutic area market size, historical approval rates for similar drugs, company fundamentals, and time-to-event proximity. Higher scores indicate catalysts more likely to generate significant price movement.
PDUFA dates are monitored in real time from SEC filings and FDA announcements. When the FDA issues a Complete Response Letter, approval, or date extension, our system captures and reflects the change within minutes. We cross-reference ClinicalTrials.gov, FDA.gov, and company 8-K filings continuously.
Yes. BiotechSigns includes a full watchlist feature that lets you follow specific companies and receive alerts when new catalysts are identified, trial status changes, or FDA actions occur. You can also filter your dashboard by watchlist to focus on the names that matter to you.
BiotechSigns tracks catalysts across eight major therapeutic sectors: oncology, immunology, neurology, cardiovascular, rare diseases, infectious disease, metabolic disorders, and gene therapy/cell therapy. Coverage is expanding as new clinical data sources are integrated.
Yes. We track trial phase transitions, interim data readouts, primary endpoint results, and regulatory milestones. Our system parses press releases and SEC filings to surface trial outcome data as soon as it becomes publicly available.
Convergence signals occur when multiple independent technical and fundamental indicators align on the same directional thesis. StonkWhisper monitors moving averages, volume profiles, options flow, institutional positioning, and momentum oscillators — when several of these converge simultaneously, the system flags it as a high-conviction signal.
Most technical analysis tools operate in isolation. StonkWhisper cross-references its technical signals with fundamental data from DilutionWatch (SEC filings, dilution risk) and BiotechSigns (catalyst events, trial data). This multi-source approach reduces false signals and adds context that pure TA tools miss.
Yes. StonkWhisper ingests market data in real time during trading hours. Signals are recalculated continuously as new price, volume, and options data flows in. After-hours and pre-market data is also captured where available.
StonkWhisper covers all major U.S. exchanges — NYSE, NASDAQ, and AMEX — with a focus on liquid equities and high-activity options chains. Coverage depth varies by tier.
LandSquatch aggregates property intelligence from public county records, FEMA flood maps, NRCS soil databases, and zoning registries across the United States. Coverage is strongest in rural and exurban markets where land-buying decisions benefit most from data aggregation.
Property data is refreshed on a regular schedule as county records and public databases update. Core parcel data, zoning changes, and flood map revisions are checked weekly. Market pricing estimates are updated as new comparable sales data becomes available.
The Parcel Fit Score evaluates how well a land parcel matches your specified criteria — including location, acreage, zoning type, flood risk, soil quality, road access, and price range. It is a convenience tool to help you quickly filter parcels, not a professional appraisal or investment recommendation.
